Get the App

Back Stocks profile

Stock analysis tool for investors

Procter & Gamble Health Ltd.

₹5086.00 -43.65 (-0.85%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

5073.00

Today’s High

5144.00

52W low

3870.10

52W High

5500.00

Open Price

5130.00

Prev. Close

5104.25

Volume

1949.00

Value

9912614.00

Fundamentals

Market Cap Cr

8442.50

Price to Earnings

36.50

Price to Book Value

11.20

Dividend Yield

1.90

PE to Growth

2.40

Op Revenue TTM Cr

1237.00

Net Profit TTM Cr

231.38

Cash From Operating Activity Cr

169.52

Return on Equity %

30.55

EMA & SMA

Bullish Moving Averages

3

Bearish Moving Averages

13

5Day EMA Rs

5143.7

10Day EMA Rs

5145.1

12Day EMA Rs

5144.4

20Day EMA Rs

5138.2

26Day EMA Rs

5132.4

50Day EMA Rs

5116.9

100Day EMA Rs

5084.3

200Day EMA Rs

4970.6

5Day SMA Rs

5142.5

10Day SMA Rs

5149.5

20Day SMA Rs

5149.6

30Day SMA Rs

5118.5

50Day SMA Rs

5101

100Day SMA Rs

5124.4

150Day SMA Rs

5098.2

200Day SMA Rs

5021.5

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Dec, 2023

87

Week

81.7

Month

73

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

5142.82

PIVOT

First Resistance

5183.53

Second Resistance

5237.42

Third Resistance

5278.13

First Support

5088.93

Second Support

5048.22

Third Support

4994.33

Relative Strength Index

49.76

Money Flow Index

57.86

MACD

11.99

MACD Signal

15.93

Average True Range

97.25

Average Directional Index

9.68

Rate of Change (21)

-0.15

Rate of Change (125)

-3.56

Commodity Channel Index

-27.2

Williams %R

-64.6

BETA

1 Month

0.11

3 Month

-0.01

1 Year

0.62

3 Year

0.14

PRICE CHANGE ANALYSIS

↓ -1.58%

1 Week

Low

High

5046.05

5232.1

↓ -1%

1 Month

Low

High

5012.3

5282

↑ 0.07%

3 Months

Low

High

4850.05

5282

↓ -4.38%

6 Months

Low

High

4753

5500

↑ 23.56%

1 Year

Low

High

3870.1

5500

Indicator Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021 Graph
Total Qtr Revenue cr 310.98 306.64 325.89 314.51 300.97 298.99 270.17 282.60 275.84 287.81 222.39
Operating Expenses Qtr Cr 216.27 255.96 243.39 199.59 206.73 236.12 199.05 216.06 194.73 236.95 188.42
Operating Profit Qtr Cr 88.66 45.22 79.66 110.38 90.82 59.04 68.77 61.84 78.07 48.44 30.73
EBIDT Qtr Cr 94.71 50.68 84.63 114.92 94.24 62.14 71.12 66.54 81.11 50.86 33.97
Depreciation Qtr Cr 6.48 6.38 5.89 9.75 7.48 7.47 6.12 6.59 6.90 7.16 7.67
Net Profit Qtr Cr 65.57 29.82 59.19 76.80 63.66 41.19 51.16 44.84 55.37 33.89 15.77
Basic EPS Qtr Rs 39.50 17.96 35.70 46.30 38.30 24.80 30.82 27.00 33.40 20.40 9.50
Indicator Jun 2023 Jun 2022 Jun 2021 Jun 2020 Dec 2019 Graph
Total Revenue Annual Cr 1248.01 1127.60 1026.83 1424.75 974.54
Operating Expenses Annual Cr 905.67 846.73 762.71 1040.45 723.02
Operating Profit Annual in Cr 323.95 267.68 246.02 315.41 203.58
Operating Profit Margin Annual % 25.96 23.74 23.96 22.14 20.89
Total Expenses Annual Cr 933.81 874.23 793.55 1069.90 740.18
EBIDT Annual Cr 342.34 280.87 264.12 384.30 251.52
EBIDT Annual margin % 27.43 24.91 25.72 26.97 25.81
Depreciation Cr 27.37 27.08 30.04 29.45 17.16
PAT Before ExtraOrdinary Items Annual Cr 229.47 192.52 176.80 254.08 158.76
Net Profit Annual Cr 229.47 192.52 176.80 254.08 158.76
Basic EPS Annual Rs 138.23 116.00 107.00 153.00 95.64
Indicator Jun 2023 Jun 2022 Jun 2021 Jun 2020 Dec 2019 Graph
Total ShareHolders Funds Annual Cr 750.89 616.49 703.71 906.34 816.81
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 46.40 41.40 43.48 42.06 27.34
Total Current Liabilities Annual Cr 303.90 235.83 238.97 227.34 222.52
Total Capital Plus Liabilities Annual Cr 1101.19 893.72 986.16 1175.74 1759.46
Fixed Assets Annual Cr 176.46 152.26 143.06 122.67 112.45
Total Non Current Assets Annual Cr 305.09 280.08 259.02 219.55 221.28
Total Current Assets Annual Cr 796.10 613.64 727.14 956.19 845.40
Total Assets Annual Cr 1101.19 893.72 986.16 1175.74 1066.68
Contingent Liabilities plus Commitments Annual Cr - 258.16 244.23 194.70 -
Indicator Jun 2023 Jun 2022 Jun 2021 Jun 2020 Dec 2019 Graph
Cash from Operating Activity Annual Cr 169.52 169.52 247.26 235.37 -130.38
Cash from Investing Activity Annual Cr -25.54 -25.54 -32.27 164.64 1269.72
Cash from Financing Annual Activity Cr -288.63 -288.63 -386.63 -883.41 -30.05
Net Cash Flow Annual Cr - -144.65 -171.64 -483.40 -
Indicator Jun 2023 Jun 2022 Jun 2021 Jun 2020 Dec 2019 Graph
Book Value Per Share Annual Rs 452.34 371.38 423.92 545.99 927.78
ROE Annual % 30.55 31.22 25.12 28.03 54.45
ROCE Annual % 39.50 38.57 31.32 37.41 9.68
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 27.84 25.20 26.18 28.34 27.14
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
EBIDT Qtr Cr
Depreciation Qtr Cr
Net Profit Qtr Cr
Basic EPS Qtr Rs
Indicator Graph
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Operating Profit Margin Annual %
Total Expenses Annual Cr
EBIDT Annual Cr
EBIDT Annual margin %
Depreciation Cr
PAT Before ExtraOrdinary Items Annual Cr
Net Profit Annual Cr
Basic EPS Annual Rs
Indicator Graph
Total ShareHolders Funds Annual Cr
Minority Interest Liability Annual Cr
Total Non Current Liabilities Annual Cr
Total Current Liabilities Annual Cr
Total Capital Plus Liabilities Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
Contingent Liabilities plus Commitments Annual Cr
Indicator Graph
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
Indicator Graph
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual
EBDIT Annual Margin %
Name Holding Percent Holding Id Pledged % Locked %
HDFC MUTUAL FUND - HDFC S&P BSE 500 ETF 2.04 10791254 - -
Name Holding Percent Holding Id Pledged % Locked %
PROCTER AND GAMBLE OVERSEAS INDIA B.V. 51.82 10791247 0 0
Name Holding Percent Holding Id
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMA 3.6 10791253
HDFC MUTUAL FUND - HDFC S&P BSE 500 ETF 2.04 10791254
LICI ASM NON PAR 2.41 10791256
Name Holding Percent Holding Id
HUF 0.65 10791265
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Nov 23, 2023 50 FINAL - Equity Share
Feb 13, 2023 45 INTERIM Feb 13, 2023 Equity Share
Nov 15, 2022 11.5 FINAL - Equity Share
May 12, 2022 41 INTERIM May 13, 2022 Equity Share
Nov 02, 2021 90 SPECIAL - Equity Share
Nov 02, 2021 40 FINAL - Equity Share
Nov 18, 2020 188 SPECIAL - Equity Share
Nov 18, 2020 42 FINAL - Equity Share
May 23, 2019 416 SPECIAL - Equity Share
May 23, 2019 24 FINAL - Equity Share
May 21, 2018 15 FINAL - Equity Share
May 25, 2017 11 FINAL - Equity Share
Apr 22, 2016 7.5 FINAL - Equity Share
Mar 30, 2015 6 FINAL - Equity Share
Mar 10, 2014 8.5 FINAL - Equity Share
Mar 07, 2013 2.5 FINAL - Equity Share
Oct 22, 2010 95 INTERIM Oct 25, 2010 Equity Share
Mar 18, 2010 20 FINAL - Equity Share
Apr 06, 2009 17.5 FINAL - Equity Share
Apr 04, 2008 10 FINAL - Equity Share
Mar 21, 2007 10 INTERIM - Equity Share
Mar 21, 2007 20 FINAL - Equity Share
Apr 12, 2006 15 FINAL - Equity Share
Jan 28, 2005 10 FINAL - Equity Share
Feb 26, 2004 10 FINAL - Equity Share
May 12, 2003 5 FINAL - Equity Share
Feb 15, 2002 - FINAL - Equity Share
Jul 02, 2001 - INTERIM Jul 16, 2001 Equity Share
May 29, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Nov 03, 2023 Quarterly Results -
Aug 23, 2023 Audited Results & Final Dividend -
May 15, 2023 Quarterly Results -
Feb 05, 2023 Quarterly Results & Interim Dividend -
Nov 11, 2022 Quarterly Results (Revised)
Aug 29, 2022 Audited Results & Final Dividend -
May 05, 2022 Quarterly Results & Interim Dividend -
Feb 09, 2022 Quarterly Results -
Nov 09, 2021 Quarterly Results -
Aug 26, 2021 Audited Results & Final Dividend -
May 06, 2021 Quarterly Results -
Feb 10, 2021 Quarterly Results -
Nov 11, 2020 Quarterly Results -
Sep 15, 2020 Quarterly Results & Final Dividend -
May 29, 2020 Quarterly Results -
Feb 07, 2020 Quarterly Results -
Nov 07, 2019 Quarterly Results -
Aug 08, 2019 Quarterly Results & Interim Dividend -
May 10, 2019 Quarterly Results -
Feb 27, 2019 Audited Results & Final Dividend -
Oct 30, 2018 Quarterly Results -
Aug 07, 2018 Quarterly Results -
Apr 27, 2018 Quarterly Results -
Mar 27, 2018 Others Appointed Mr. Milind Thatte, General Manager Healthcare, as an Additional Director and Managing Director of the Company, in place of Mr. Anand Nambiar, the present MD of the Company.
Feb 22, 2018 Audited Results & Dividend -
Nov 14, 2017 Quarterly Results -
Aug 07, 2017 Quarterly Results -
May 03, 2017 Quarterly Results -
Feb 27, 2017 Audited Results & Dividend -
Nov 11, 2016 Quarterly Results -
Jul 25, 2016 Quarterly Results -
May 12, 2016 Quarterly Results -
Apr 04, 2016 Others To change of Registrar to an Issue and Share Transfer Agent (RTA) from Sharepro Services (India) Private Limited to Karvy Computershare Private Limited.
Feb 26, 2016 Audited Results & Dividend -
Dec 21, 2015 Shifting of Registered Office & Others Policy on Determining and Disclosure of Material Events/Information as required under Reg. 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 effective December.
Oct 30, 2015 Quarterly Results -
Aug 12, 2015 Quarterly Results -
May 07, 2015 Quarterly Results -
Feb 05, 2015 Audited Results & Dividend for the year 31/12/2014
Nov 13, 2014 Quarterly Results -
Aug 12, 2014 Quarterly Results -
Apr 30, 2014 Quarterly Results -
Jan 31, 2014 Audited, Quarterly Results & Dividend -
Oct 21, 2013 Quarterly Results -
Jul 29, 2013 Quarterly Results -
Apr 26, 2013 Quarterly Results -
Jan 30, 2013 Audited Results & Dividend -
Oct 22, 2012 Quarterly Results -
Jul 23, 2012 To consider appointment of M.D. inter alia, to consider appointment of Dr. Claus-Dieter Boedecker as M.D. of the Company w.e.f. August 01, 2012 in place of Dr. Marek Dziki whose term of appointment is expiring on July 31, 2012.
Apr 20, 2012 Quarterly Results First Quarter
Feb 28, 2012 Audited Results (Revised)
Nov 01, 2011 Quarterly Results -
Jul 26, 2011 Quarterly Results -
Apr 25, 2011 Quarterly Results -
Feb 08, 2011 Audited & Quarterly Results -
Oct 20, 2010 Quarterly Results & Interim Dividend -
Jul 28, 2010 Quarterly Results -
Apr 23, 2010 Quarterly Results -
Mar 29, 2010 Appointment of Additional Director The Board has approved the appointment of Mr. Pramod Pimplikar, VP -Technical Operations of the Company as Additional Director with effect from April 01, 2010.
Jan 22, 2010 Audited Results & Dividend -
Oct 15, 2009 Quarterly Results -
Jul 20, 2009 Quarterly Results -
May 20, 2009 Buy Back of Shares To approve a buy-back of its fully paid equity shares of the face value of Rs 10/- up to an amount of Rs 451.1 million being not more than 10% of the total paid up capital and free reserves.
Apr 20, 2009 Quarterly Results -
Feb 26, 2009 Audited Results & Dividend -
Oct 30, 2008 Quarterly Results -
Jul 30, 2008 Quarterly Results -
Apr 16, 2008 Quarterly Results -
Jan 30, 2008 Audited Results & Dividend -
Oct 18, 2007 Quarterly Results -
Jul 16, 2007 Quarterly Results -
Apr 20, 2007 Quarterly Results -
Mar 16, 2007 Interim Dividend (Revised)
Jan 22, 2007 Accounts & Quarterly Results -
Oct 19, 2006 Quarterly Results -
Jul 28, 2006 Quarterly & Half Yearly Results -
Apr 26, 2006 Quarterly Results -
Jan 27, 2006 Accounts & Dividend -
Jan 06, 2006 Others Consider inter alia, proposal to sell Companys Life Science and Analytics Division (excluding bulk drugs) to Merck Specialities Pvt. Ltd., a 100% Subsidiary of Merck KGaA, Germany.
Oct 29, 2005 Quarterly Results -
Jul 29, 2005 Quarterly Results -
Apr 13, 2005 Quarterly Results -
Jan 18, 2005 Dividend & Accounts -
Oct 28, 2004 Quarterly Results -
Jul 31, 2004 Quarterly Results -
Apr 19, 2004 Quarterly Results -
Jan 27, 2004 Dividend & Accounts -
Oct 15, 2003 Quarterly Results -
Jul 22, 2003 Half Yearly Results -
Apr 15, 2003 Quarterly Results -
Mar 20, 2003 Dividend Reconsider the rate of dividend recommended for the year 2002 in the Board Meeting 27.01.2003.
Jan 27, 2003 Dividend & Others Employees Stock Option Plan
Oct 29, 2002 Quarterly Results -
Jul 12, 2002 Quarterly Results -
Apr 18, 2002 Quarterly Results -
Mar 09, 2002 Interim Dividend -
Jan 29, 2002 Accounts & Final Dividend -
Oct 25, 2001 Quarterly Results -
Jul 18, 2001 Quarterly Results -
Jun 27, 2001 Interim Dividend -
Apr 27, 2001 Quarterly Results -
Feb 09, 2001 Accounts -
Oct 19, 2000 Quarterly Results -
Jul 21, 2000 Half Yearly Results -
Apr 24, 2000 Quarterly Results & Interim Dividend -
Feb 18, 2000 Accounts -
Oct 25, 1999 Quarterly Results -
Jul 24, 1999 Quarterly Results -
Jul 23, 1999 Half Yearly Results -
Apr 27, 1999 Quarterly Results -
Feb 27, 1999 Accounts. -
Oct 19, 1998 Quarterly Results -
Mar 13, 1998 Accounts -
Ex-Date Bonus Ratio Record Date
Bigul
04 Dec 2023

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sir, We request you to kindly note that we have issued duplicate share certificate to our shareholders, as detailed in enclosed letter.
Bigul
04 Dec 2023

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sir, We are informed by our RTA regarding loss of share certificate of our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.
Bigul
01 Dec 2023

Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Find enclosed the scrutinizers'' report on the voting and remote evoting with respect to the 56th AGM held on November 30,2023.
Bigul
01 Dec 2023

Procter & Gamble Health Ltd - 500126 - Disclosure Of Voting Results Of The 56Th Annual General Meeting Of Shareholders Held On November 30, 2023

 We would like to inform you that the 56th Annual General Meeting was held on November 30,2023 at 3:33 p.m. In this respect find enclosed the voting result and scrutinizers report.
Bigul
01 Dec 2023

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Find details with respect to intimation received with respect to share certificate(s) lost by shareholder(s) of the Company
Bigul
01 Dec 2023

Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 We would like to inform you that the 56th Annual General Meeting of the Company was held on November 30,2023 at 3:30 p.m. through video conference/ other audio visual means. Find enclosed a copy of presentation on business review of the Company as presented at the 56th Annual General Meeting.
Bigul
21 Nov 2023

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sir, We have been informed by our RTA regarding issuance of share certificate, as detailed in enclosed letter. Request you to kindly take the same on record. Thanking You.
Bigul
16 Nov 2023

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sir, We have received intimation regarding loss of share certificate, as detailed in enclosed letter. Request you to kindly take note of the same.
Bigul
10 Nov 2023

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sir, We have been informed by our shareholder regarding loss of share certificate, as detailed in enclosed letter. Request you to kindly take note of the same.
Bigul
08 Nov 2023

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Find enclosed details with respect to duplicate share certificates issued to shareholders of the Company
See all News

FAQs

The latest market price of Procter & Gamble Health Ltd. on NSE was Rs. 5086.00 as of today.

The opening share price of Procter & Gamble Health Ltd. was Rs. 5130.00 as of today.

The 52-week high share price of Procter & Gamble Health Ltd. was Rs. 5500.00.

The 52 week low share price of Procter & Gamble Health Ltd. was Rs. 3870.10.

Procter & Gamble Health Ltd. has a market cap of Rs. 8442.50 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Procter & Gamble Health Ltd. is 2.40. Please refer to the Fundamentals section for further details.

The operating revenue for Procter & Gamble Health Ltd. in the last FY was Rs.  1237.00 crore. Please refer to the Financials section for further details.

The Net Profit for Procter & Gamble Health Ltd. in the last FY was Rs. 231.38 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Procter & Gamble Health Ltd. was on 2023-11-23 for Rs. 50 per share. According to today’s share price, the dividend yield of Procter & Gamble Health Ltd. stands at 1.90. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Procter & Gamble Health Ltd..